Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.12 EUR | +0.75% | +1.12% | +16.73% |
04:47pm | GSK: licensing agreement with Ochre Bio | CF |
Jun. 11 | Health Care Down as Rally Pauses -- Health Care Roundup | DJ |
Sales 2024 * | 31.66B 40.68B 37.5B | Sales 2025 * | 33.63B 43.2B 39.83B | Capitalization | 65.86B 84.6B 78.01B |
---|---|---|---|---|---|
Net income 2024 * | 5.57B 7.16B 6.6B | Net income 2025 * | 6.52B 8.37B 7.72B | EV / Sales 2024 * | 2.47 x |
Net Debt 2024 * | 12.23B 15.71B 14.48B | Net Debt 2025 * | 8.75B 11.24B 10.37B | EV / Sales 2025 * | 2.22 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
10.1
x | Employees | 70,212 |
Yield 2024 * |
3.76% | Yield 2025 * |
3.9% | Free-Float | 94.54% |
Latest transcript on GSK plc
1 day | +0.79% | ||
1 week | +1.12% | ||
Current month | -4.95% | ||
1 month | -7.48% | ||
3 months | -1.14% | ||
6 months | +15.30% | ||
Current year | +16.73% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 19.48 | +2.64% | 2 050 |
24-06-11 | 18.98 | -0.50% | 545 |
24-06-10 | 19.07 | +0.37% | 233 |
24-06-07 | 19 | -0.03% | 0 |
24-06-06 | 19 | -1.32% | 170 |
Delayed Quote Deutsche Boerse AG, June 12, 2024 at 09:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.35% | 780B | |
+41.76% | 627B | |
+19.92% | 334B | |
+7.11% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.59% | 161B | |
-3.46% | 159B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock